Technical Analysis for GTH - Genetron Holdings Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 4.03 | 0.12% | 0.01 |
GTH closed up 0.12 percent on Thursday, March 28, 2024, on 7.97 times normal volume. The bulls were able to push the stock to a new 52-week high. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| New 52 Week Closing High | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 01/18/2024
Genetron Holdings Limited is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Cancer Treatment Oncology Molecular Biology Precision Medicine Systems Biology Cancer Care Evidence Based Medicine
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Cancer Treatment Oncology Molecular Biology Precision Medicine Systems Biology Cancer Care Evidence Based Medicine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.05 |
| 52 Week Low | 2.0802 |
| Average Volume | 51,764 |
| 200-Day Moving Average | 3.31 |
| 50-Day Moving Average | 3.87 |
| 20-Day Moving Average | 3.93 |
| 10-Day Moving Average | 3.96 |
| Average True Range | 0.03 |
| RSI (14) | 70.59 |
| ADX | 37.04 |
| +DI | 39.03 |
| -DI | 13.48 |
| Chandelier Exit (Long, 3 ATRs) | 3.95 |
| Chandelier Exit (Short, 3 ATRs) | 3.94 |
| Upper Bollinger Bands | 4.05 |
| Lower Bollinger Band | 3.81 |
| Percent B (%b) | 0.9 |
| BandWidth | 6.01 |
| MACD Line | 0.04 |
| MACD Signal Line | 0.03 |
| MACD Histogram | 0.0098 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.07 | ||||
| Resistance 3 (R3) | 4.07 | 4.06 | 4.06 | ||
| Resistance 2 (R2) | 4.06 | 4.05 | 4.06 | 4.06 | |
| Resistance 1 (R1) | 4.04 | 4.04 | 4.05 | 4.04 | 4.06 |
| Pivot Point | 4.03 | 4.03 | 4.04 | 4.03 | 4.03 |
| Support 1 (S1) | 4.01 | 4.02 | 4.02 | 4.01 | 3.99 |
| Support 2 (S2) | 4.00 | 4.01 | 4.00 | 3.99 | |
| Support 3 (S3) | 3.98 | 4.00 | 3.99 | ||
| Support 4 (S4) | 3.98 |
